CAI Stock Summary and Trading Ideas (Caris Life Sciences | NASDAQ:CAI)

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Caris Life Sciences trades on the NASDAQ stock market under the symbol CAI.

As of March 17, 2026, CAI stock price declined to $18.54 with 1,984,575 million shares trading.

CAI has a beta of 2.00, meaning it tends to be more sensitive to market movements. CAI has a correlation of 0.16 to the broad based SPY ETF.

CAI has a market cap of $5.23 billion. This is considered a Mid Cap stock.

Last quarter Caris Life Sciences reported $293 million in Revenue and $.28 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.21.

The top ETF exchange traded funds that CAI belongs to (by Net Assets): IBB, IDNA, IWR, IWP, ONEQ.

CAI support price is $18.27 and resistance is $19.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CAI shares will trade within this expected range on the day.